$1.1 Million Revenue Clinical Research Company in Texas with Strong Study Pipeline
Texas Clinical Research Company with 25 Active Clients
On NextCompany since August 27, 2026 (48 days)
TX areaEstablished 20069 FT employees
Business overview
Texas operates a clinical research company with a strong study pipeline since 2006. The company manages trials for approximately 25 active pharmaceutical clients. Staff includes 8 to 10 full-time and 6 to 8 contract employees. Projected 2026 revenue reaches $1,100,000 with adjusted EBITDA of $350,000. Owned real estate supports operations but remains excluded from the price. The asking price is $3,000,000.
Who is a good fit for this business
- Strategic buyers expanding in clinical research value the 25-client base.
- Investors comfortable with separate real estate transactions suit this Texas opportunity.
- Buyers open to rolled equity arrangements find the seller flexible.
Details
- Reason for selling
- The primary owner is seeking to transition into retirement over the next few years.
- Real estate
- Owned, available separately
Frequently Asked Questions
The company works with approximately 25 active pharmaceutical clients. It has operated since 2006 in a major Texas metropolitan area. Many new studies sit in the pipeline.
Projected 2026 revenue stands at $1,100,000. Adjusted EBITDA reaches $350,000. The asking price is $3,000,000 and excludes real estate.
Staff includes 8 to 10 full-time employees and 6 to 8 contract employees. The primary owner seeks retirement over the next few years. The seller may consider rolled equity.
Owned real estate supports operations but stays excluded from the asking price. The seller may consider rolled equity with a suitable partner.